Yumanity Therapeutics Information
Contact top employees from
Yumanity Therapeutics
Summary
Yumanity Therapeutics is a private company that has been in the industry for 11 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the President & CEO is occupied by Richard Peters. Its headquarters is located at Boston, Massachusetts, USA. The number of employees ranges from 25 to 100. The annual revenue of Yumanity Therapeutics varies between 5.0M and 25M. Total funding of the company - $103.8M. To connect with Yumanity Therapeutics employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
10-50 employees
SIC Code
2836
DMA Code
Greater Boston
Founded
2014
Estimated Annual Revenue
$5.0M - 25M
Operating Status
Acquired
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2015 | Privately Held | 25 - 100 | 6M | $36M | |
| 2013 | Public Company | 100 - 250 | 24.6M | $407.5M | |
| 2008 | Privately Held | 100 - 250 | 30M | $438M | |
| 2008 | Privately Held | 25 - 100 | 2M | $895K | |
| 2018 | - | 10-50 | - | $- |
Employees Turnover 3 quarter 2025
Length of Employment
Employee tenure at Yumanity Therapeutics shows a diverse range of experience levels:
24% for 3–4 years41% for 5–7 years35% for 8–10 yearsContact top employees from
Yumanity Therapeutics
Brigitte Robertson MD
Chief Medical Officer
Vikram Khurana
Scientific Co-Founder and Senior Advisor
Michelle Skupien
Vice President Development Operations
Rich Heyman
BOD Member
Tony Coles
Chairman
Similar Companies
FAQ
Yumanity Therapeutics operates in the Biotechnology industries. More details can be found on the official website: kinetabio.com.
The headquarters of Yumanity Therapeutics are located in Boston, United States.
The current CEO of Yumanity Therapeutics is Richard Peters
You can contact Yumanity Therapeutics by phone at 617-409-5300.
Yumanity Therapeutics currently employs 10-50 people.
Yumanity Therapeutics's revenue is approximately 6M.
Well-known competitors of Yumanity Therapeutics include Verge Genomics, Alector, Samumed, LLC and ICB International, Inc..
